PHARMACEUTICAL COMPOSITION WITH TUMOR NECROSIS FACTOR A AND 2-METHOXYESTRONE-3-O-SULPHAMATE FOR INHIBITION OF ESTRONE SULPHATASE
摘要
A composition is described. The composition comprises i) a compound comprising a sulphamate group ("a sulphamate compound"); and ii) a biological response modifier.